Markets Rally on AI While Tariff Fears Persist

Don’t Stop Here

More To Explore

GOSS: Urgent Action Needed Before Class Action Deadline!

Company Overview Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company focused on developing seralutinib, an inhaled therapy for pulmonary arterial hypertension (PAH) (ir.gossamerbio.com).